Literature DB >> 17622380

Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy.

Pi Chi Lin1, Jen Te Hsu, Chang Min Chung, Shih Tai Chang.   

Abstract

We report the case of a 65-year-old man with a 6-year history of hypertension who presented with dilated cardiomyopathy, a transient cerebrovascular event, paroxysmal sweating, and intractable hypertension. Coronary angiography revealed no abnormality, but diagnostic testing was pursued because of the severe sweating and hypertension. Two-dimensional echocardiography showed 4-chamber dilatation with decreased left ventricular contractility. Further investigation, including a computed tomographic scan of the abdomen, led to a diagnosis of pheochromocytoma. Surgical resection of a left adrenal pheochromocytoma quickly resolved the patient's hypertension and resulted in substantially improved cardiac function after 4 months. Although pheochromocytoma has rarely been reported in the presence of both dilated cardiomyopathy and cerebrovascular events, it should be included in the differential diagnosis when patients present with dilated cardiomyopathy and a cerebrovascular event that have no obvious cause.

Entities:  

Mesh:

Year:  2007        PMID: 17622380      PMCID: PMC1894695     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  13 in total

1.  Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations.

Authors:  J B Lam; C Shub; S G Sheps
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

2.  Catecholamine cardiomyopathy.

Authors:  S Bloom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

3.  Reversible cerebral ischemia in patients with pheochromocytoma.

Authors:  F S Lehmann; P Weiss; R Ritz; F Harder; J J Staub
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Cerebrovascular event, dilated cardiomyopathy, and pheochromocytoma.

Authors:  Maria I Dagartzikas; Kelly Sprague; Guy Carter; Joseph D Tobias
Journal:  Pediatr Emerg Care       Date:  2002-02       Impact factor: 1.454

5.  CNS pseudovasculitis in a patient with pheochromocytoma.

Authors:  M Razavi; B Bendixen; J E Maley; M Shoaib; M Zargarian; B Razavi; H P Adams
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

6.  Acute cardiac events temporally related to cocaine abuse.

Authors:  J M Isner; N A Estes; P D Thompson; M R Costanzo-Nordin; R Subramanian; G Miller; G Katsas; K Sweeney; W Q Sturner
Journal:  N Engl J Med       Date:  1986-12-04       Impact factor: 91.245

7.  Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure.

Authors:  S H Sardesai; A J Mourant; Y Sivathandon; R Farrow; D O Gibbons
Journal:  Br Heart J       Date:  1990-04

8.  Permeability alteration of sarcolemmal membrane in catecholamine-induced cardiac muscle cell injury. In vivo studies with fine structural diffusion tracer horse radish peroxidase.

Authors:  M Boutet; I Hüttner; G Rona
Journal:  Lab Invest       Date:  1976-05       Impact factor: 5.662

Review 9.  Reversal of severe cardiac systolic dysfunction caused by pheochromocytoma in a heart transplant candidate.

Authors:  R J Quigg; A Om
Journal:  J Heart Lung Transplant       Date:  1994 May-Jun       Impact factor: 10.247

10.  EXPERIMENTAL MYOCARDITIS; A STUDY OF THE HISTOLOGICAL CHANGES FOLLOWING INTRAVENOUS INJECTIONS OF ADRENALIN.

Authors:  R M Pearce
Journal:  J Exp Med       Date:  1906-05-25       Impact factor: 14.307

View more
  7 in total

1.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 2.  PRECISION MEDICINE: AN UPDATE ON GENOTYPE/BIOCHEMICAL PHENOTYPE RELATIONSHIPS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA PATIENTS.

Authors:  Garima Gupta; Karel Pacak
Journal:  Endocr Pract       Date:  2017-03-23       Impact factor: 3.443

3.  Pheochromocytoma triggered by coronavirus disease 2019: a case report.

Authors:  Hoda Naghshineh; Amirhossein Hasanpour; Naghmeh Ziaei; Mahmoud Sadeghi; Neda Meftah
Journal:  J Med Case Rep       Date:  2022-06-10

4.  Phaeochromocytoma presenting as Takotsubo cardiomyopathy.

Authors:  Oluwatosin Kayode; Paul Underwood; Ravi Dissanayake; David Scott-Coombes; Subramaniam Nagasayi
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

5.  The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study.

Authors:  Ryszard Pogorzelski; Sadegh Toutounchi; Ewa Krajewska; Patryk Fiszer; Marcin Łykowski; Łukasz Zapała; Małgorzata Szostek; Wawrzyniec Jakuczun; Janusz Pachucki; Maciej Skórski
Journal:  Cent European J Urol       Date:  2014-12-05

6.  Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmonary hemorrhage, and cyclic hypotension: case report and review of unusual presentations of pheochromocytoma.

Authors:  Meyeon Park; Katarzyna Hryniewicz; John F Setaro
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-02       Impact factor: 3.738

7.  Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cells.

Authors:  Jason Arsenault; Enrico Ferrari; Dhevahi Niranjan; Sabine A G Cuijpers; Chunjing Gu; Yvonne Vallis; John O'Brien; Bazbek Davletov
Journal:  J Neurochem       Date:  2013-05-20       Impact factor: 5.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.